NCT05856643

Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial Carcinoma

Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial

• Status: Recruiting
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 12 (estimated)
• Sponsor: Shantou University Medical College · Academic / Other
• Sex: Female
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

This study was a single-center, open-label, investigator-initiated clinical trial (IIT) to observe and investigate the clinical safety and efficacy of SZ011 in the treatment of ovarian epithelial carcinoma

Conditions

• Ovarian Epithelial Carcinoma

Interventions

Type	Name	Description
DRUG	SZ011 CAR-NK	In the escalation study, the minimum initial dose was 5.0×10\^6 cells, then increased to 1.0×10\^8, 2.0×10\^8and 5.0×10\^8 cells. The infusion is given every 2 weeks.

Timeline

• Start date: 2024-08-13
• Primary completion: 2025-06-01
• Completion: 2025-12-30
• First posted: 2023-05-12
• Last updated: 2024-08-13

Locations

1 site across 1 country: China